Comparative tumorigenicity of 6-nitrochrysene and its metabolites in newborn mice

Karam El-Bayoumy, Gong Huey Shiue, Stephen S. Hecht

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

The tumorigenic activities of 6-nitrochrysene and its metabolites were evaluated in the newborn mouse model. Groups of mice were treated with the appropriate compounds in DMSO by i.p. injections on the 1st, 8th and 15th day of life. Seven hundred nmol/mouse of 6-nitrochrysene induced significant incidences and multiplicities of lung tumors in both sexes; only males were susceptible to liver tumor induction. At 100 nmol/mouse, 6-nitrochrysene had significant tumori-genicity in both lung and liver but was less active than at the higher dose. Administration of 100 nmol/mouse of 6-nitrochrysene, only on day 1, caused about the same tumor yield as was observed after treatment with 700 nmol/mouse given over 3 days. Among the metabolites of 6-nitrochrysene which were tested at 100 nmol/mouse, 6-nitrosochrysene and 6-aminochrysene were significantly less active in the lung and in the liver than 6-nitrochrysene. In the lung and trans-1, 2-dmydro-ld1hyd xy-6-nitn chrysene and trans-l, 2-dihydro-l, 2-dihydroxy-6-aminochysene had activities comparable to those observed in mice treated with equimolar doses of 6-nitrochrysene. In the liver, trans-l, 2-dihydro-l, 2-dihydroxy-6-nitrochrysene was more active than 6-nitrochrysene based on the number of tumors per mouse. These observations support our hypothesis that 6-nitrochrysene is metabolically activated by ring-oxidation to trans-1, 2-dihydro-1, 2-dihydroxy-6-nitrochrysene, followed by nitro-reduction to trans-1, 2-dihydro-1, 2-dihydroxy-6-amino-chrysene and, finally, oxidation to a diol-apoxide.

Original languageEnglish (US)
Pages (from-to)369-372
Number of pages4
JournalCarcinogenesis
Volume10
Issue number2
DOIs
StatePublished - Feb 1 1989

Fingerprint

Lung
Liver
Neoplasms
6-nitrochrysene
Dimethyl Sulfoxide
Injections
Incidence
chrysene
Therapeutics
6-chrysenamine
1,2-dihydro-1,2-dihydroxy-6-nitrochrysene

All Science Journal Classification (ASJC) codes

  • Cancer Research

Cite this

El-Bayoumy, Karam ; Shiue, Gong Huey ; Hecht, Stephen S. / Comparative tumorigenicity of 6-nitrochrysene and its metabolites in newborn mice. In: Carcinogenesis. 1989 ; Vol. 10, No. 2. pp. 369-372.
@article{3fc2de78d3c4494c8d34e05b2e230dc4,
title = "Comparative tumorigenicity of 6-nitrochrysene and its metabolites in newborn mice",
abstract = "The tumorigenic activities of 6-nitrochrysene and its metabolites were evaluated in the newborn mouse model. Groups of mice were treated with the appropriate compounds in DMSO by i.p. injections on the 1st, 8th and 15th day of life. Seven hundred nmol/mouse of 6-nitrochrysene induced significant incidences and multiplicities of lung tumors in both sexes; only males were susceptible to liver tumor induction. At 100 nmol/mouse, 6-nitrochrysene had significant tumori-genicity in both lung and liver but was less active than at the higher dose. Administration of 100 nmol/mouse of 6-nitrochrysene, only on day 1, caused about the same tumor yield as was observed after treatment with 700 nmol/mouse given over 3 days. Among the metabolites of 6-nitrochrysene which were tested at 100 nmol/mouse, 6-nitrosochrysene and 6-aminochrysene were significantly less active in the lung and in the liver than 6-nitrochrysene. In the lung and trans-1, 2-dmydro-ld1hyd xy-6-nitn chrysene and trans-l, 2-dihydro-l, 2-dihydroxy-6-aminochysene had activities comparable to those observed in mice treated with equimolar doses of 6-nitrochrysene. In the liver, trans-l, 2-dihydro-l, 2-dihydroxy-6-nitrochrysene was more active than 6-nitrochrysene based on the number of tumors per mouse. These observations support our hypothesis that 6-nitrochrysene is metabolically activated by ring-oxidation to trans-1, 2-dihydro-1, 2-dihydroxy-6-nitrochrysene, followed by nitro-reduction to trans-1, 2-dihydro-1, 2-dihydroxy-6-amino-chrysene and, finally, oxidation to a diol-apoxide.",
author = "Karam El-Bayoumy and Shiue, {Gong Huey} and Hecht, {Stephen S.}",
year = "1989",
month = "2",
day = "1",
doi = "10.1093/carcin/10.2.369",
language = "English (US)",
volume = "10",
pages = "369--372",
journal = "Carcinogenesis",
issn = "0143-3334",
publisher = "Oxford University Press",
number = "2",

}

Comparative tumorigenicity of 6-nitrochrysene and its metabolites in newborn mice. / El-Bayoumy, Karam; Shiue, Gong Huey; Hecht, Stephen S.

In: Carcinogenesis, Vol. 10, No. 2, 01.02.1989, p. 369-372.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Comparative tumorigenicity of 6-nitrochrysene and its metabolites in newborn mice

AU - El-Bayoumy, Karam

AU - Shiue, Gong Huey

AU - Hecht, Stephen S.

PY - 1989/2/1

Y1 - 1989/2/1

N2 - The tumorigenic activities of 6-nitrochrysene and its metabolites were evaluated in the newborn mouse model. Groups of mice were treated with the appropriate compounds in DMSO by i.p. injections on the 1st, 8th and 15th day of life. Seven hundred nmol/mouse of 6-nitrochrysene induced significant incidences and multiplicities of lung tumors in both sexes; only males were susceptible to liver tumor induction. At 100 nmol/mouse, 6-nitrochrysene had significant tumori-genicity in both lung and liver but was less active than at the higher dose. Administration of 100 nmol/mouse of 6-nitrochrysene, only on day 1, caused about the same tumor yield as was observed after treatment with 700 nmol/mouse given over 3 days. Among the metabolites of 6-nitrochrysene which were tested at 100 nmol/mouse, 6-nitrosochrysene and 6-aminochrysene were significantly less active in the lung and in the liver than 6-nitrochrysene. In the lung and trans-1, 2-dmydro-ld1hyd xy-6-nitn chrysene and trans-l, 2-dihydro-l, 2-dihydroxy-6-aminochysene had activities comparable to those observed in mice treated with equimolar doses of 6-nitrochrysene. In the liver, trans-l, 2-dihydro-l, 2-dihydroxy-6-nitrochrysene was more active than 6-nitrochrysene based on the number of tumors per mouse. These observations support our hypothesis that 6-nitrochrysene is metabolically activated by ring-oxidation to trans-1, 2-dihydro-1, 2-dihydroxy-6-nitrochrysene, followed by nitro-reduction to trans-1, 2-dihydro-1, 2-dihydroxy-6-amino-chrysene and, finally, oxidation to a diol-apoxide.

AB - The tumorigenic activities of 6-nitrochrysene and its metabolites were evaluated in the newborn mouse model. Groups of mice were treated with the appropriate compounds in DMSO by i.p. injections on the 1st, 8th and 15th day of life. Seven hundred nmol/mouse of 6-nitrochrysene induced significant incidences and multiplicities of lung tumors in both sexes; only males were susceptible to liver tumor induction. At 100 nmol/mouse, 6-nitrochrysene had significant tumori-genicity in both lung and liver but was less active than at the higher dose. Administration of 100 nmol/mouse of 6-nitrochrysene, only on day 1, caused about the same tumor yield as was observed after treatment with 700 nmol/mouse given over 3 days. Among the metabolites of 6-nitrochrysene which were tested at 100 nmol/mouse, 6-nitrosochrysene and 6-aminochrysene were significantly less active in the lung and in the liver than 6-nitrochrysene. In the lung and trans-1, 2-dmydro-ld1hyd xy-6-nitn chrysene and trans-l, 2-dihydro-l, 2-dihydroxy-6-aminochysene had activities comparable to those observed in mice treated with equimolar doses of 6-nitrochrysene. In the liver, trans-l, 2-dihydro-l, 2-dihydroxy-6-nitrochrysene was more active than 6-nitrochrysene based on the number of tumors per mouse. These observations support our hypothesis that 6-nitrochrysene is metabolically activated by ring-oxidation to trans-1, 2-dihydro-1, 2-dihydroxy-6-nitrochrysene, followed by nitro-reduction to trans-1, 2-dihydro-1, 2-dihydroxy-6-amino-chrysene and, finally, oxidation to a diol-apoxide.

UR - http://www.scopus.com/inward/record.url?scp=0024494431&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024494431&partnerID=8YFLogxK

U2 - 10.1093/carcin/10.2.369

DO - 10.1093/carcin/10.2.369

M3 - Article

VL - 10

SP - 369

EP - 372

JO - Carcinogenesis

JF - Carcinogenesis

SN - 0143-3334

IS - 2

ER -